Statement Of Cash Flows [Abstract]

Optomed Oyj - Filing #2160892

Concept 2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income (cost)
468,000 EUR
618,000 EUR
Cash flows from (used in) operations before changes in working capital
1,491,000 EUR
2,479,000 EUR
Adjustments for decrease (increase) in trade and other receivables
1,094,000 EUR
204,000 EUR
Adjustments for increase (decrease) in trade and other payables
75,000 EUR
172,000 EUR
Adjustments for depreciation and amortisation expense and impairment loss (reversal of impairment loss) recognised in profit or loss
2,193,000 EUR
3,145,000 EUR
Finance costs paid, classified as operating activities
93,000 EUR
123,000 EUR
Cash flows from (used in) financing activities [abstract]
Payments for share issue costs
318,000 EUR
682,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.